4.8 Article

ChimerDB 3.0: an enhanced database for fusion genes from cancer transcriptome and literature data mining

Journal

NUCLEIC ACIDS RESEARCH
Volume 45, Issue D1, Pages D784-D789

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkw1083

Keywords

-

Funding

  1. National Research Foundation of Korea [NRF-2014M3C9A3065221, NRF-2015K1A4A3047851, NRF-2014R1A2A1A10051238]
  2. KRIBB Research Initiative Program
  3. Technology Innovation Program of the Ministry of Trade, Industry and Energy, Republic of Korea [10050154]
  4. National Research Foundation of Korea [2014M3C9A3065221] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

Ask authors/readers for more resources

Fusion gene is an important class of therapeutic targets and prognostic markers in cancer. ChimerDB is a comprehensive database of fusion genes encompassing analysis of deep sequencing data and manual curations. In this update, the database coverage was enhanced considerably by adding two new modules of The Cancer Genome Atlas (TCGA) RNA-Seq analysis and PubMed abstract mining. ChimerDB 3.0 is composed of three modules of ChimerKB, ChimerPub and ChimerSeq. ChimerKB represents a knowledgebase including 1066 fusion genes with manual curation that were compiled from public resources of fusion genes with experimental evidences. ChimerPub includes 2767 fusion genes obtained from text mining of PubMed abstracts. ChimerSeq module is designed to archive the fusion candidates from deep sequencing data. Importantly, we have analyzed RNA-Seq data of the TCGA project covering 4569 patients in 23 cancer types using two reliable programs of FusionScan and TopHat-Fusion. The new user interface supports diverse search options and graphic representation of fusion gene structure. ChimerDB 3.0 is available at http://ercsb.ewha.ac.kr/fusiongene/.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available